These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28954820)

  • 21. Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms.
    Cristiano C; Pirozzi C; Coretti L; Cavaliere G; Lama A; Russo R; Lembo F; Mollica MP; Meli R; Calignano A; Mattace Raso G
    Brain Behav Immun; 2018 Nov; 74():166-175. PubMed ID: 30193877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid receptor 2 agonist promotes parameters implicated in mucosal healing in patients with inflammatory bowel disease.
    Tartakover Matalon S; Ringel Y; Konikoff F; Drucker L; Pery S; Naftali T
    United European Gastroenterol J; 2020 Apr; 8(3):271-283. PubMed ID: 32213014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFNgamma, TNFalpha and IL-1beta on viability, butyrate oxidation and IL-8 secretion.
    Pedersen G; Saermark T; Bendtzen K; Brynskov J
    Autoimmunity; 2000 Dec; 32(4):255-63. PubMed ID: 11191284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
    Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
    Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Cannabidiol on the In Vitro Lymphocyte Pro-Inflammatory Cytokine Production of Senior Horses.
    Turner S; Barker VD; Adams AA
    J Equine Vet Sci; 2021 Aug; 103():103668. PubMed ID: 34281647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory effect of palmitoylethanolamide on human adipocytes.
    Hoareau L; Buyse M; Festy F; Ravanan P; Gonthier MP; Matias I; Petrosino S; Tallet F; d'Hellencourt CL; Cesari M; Di Marzo V; Roche R
    Obesity (Silver Spring); 2009 Mar; 17(3):431-8. PubMed ID: 19131941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabidiol Effects on Phospholipid Metabolism in Keratinocytes from Patients with Psoriasis Vulgaris.
    Jarocka-Karpowicz I; Biernacki M; Wroński A; Gęgotek A; Skrzydlewska E
    Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32121131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model.
    Harvey BS; Sia TC; Wattchow DA; Smid SD
    Cytokine; 2014 Feb; 65(2):236-44. PubMed ID: 24238999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol.
    Sunda F; Arowolo A
    FASEB J; 2020 Nov; 34(11):14083-14092. PubMed ID: 32885502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator.
    Manzo E; Schiano Moriello A; Tinto F; Verde R; Allarà M; De Petrocellis L; Pagano E; Izzo AA; Di Marzo V; Petrosino S
    Cells; 2021 Feb; 10(2):. PubMed ID: 33672574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabidiol in inflammatory bowel diseases: a brief overview.
    Esposito G; Filippis DD; Cirillo C; Iuvone T; Capoccia E; Scuderi C; Steardo A; Cuomo R; Steardo L
    Phytother Res; 2013 May; 27(5):633-6. PubMed ID: 22815234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol - studies in BV-2 microglia and encephalitogenic T cells.
    Juknat A; Kozela E; Kaushansky N; Mechoulam R; Vogel Z
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):289-96. PubMed ID: 26540221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor α mediates acute effects of palmitoylethanolamide on sensory neurons.
    Khasabova IA; Xiong Y; Coicou LG; Piomelli D; Seybold V
    J Neurosci; 2012 Sep; 32(37):12735-43. PubMed ID: 22972997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.
    De Filippis D; Esposito G; Cirillo C; Cipriano M; De Winter BY; Scuderi C; Sarnelli G; Cuomo R; Steardo L; De Man JG; Iuvone T
    PLoS One; 2011; 6(12):e28159. PubMed ID: 22163000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single-centre randomized evaluator-blinded clinical and in vitro studies in normal skin.
    Maghfour J; Rietcheck H; Szeto MD; Rundle CW; Sivesind TE; Dellavalle RP; Lio P; Dunnick CA; Fernandez J; Yardley H
    Clin Exp Dermatol; 2021 Dec; 46(8):1518-1529. PubMed ID: 34022073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineered
    Esposito G; Pesce M; Seguella L; Lu J; Corpetti C; Del Re A; De Palma FDE; Esposito G; Sanseverino W; Sarnelli G
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice.
    Li K; Feng JY; Li YY; Yuece B; Lin XH; Yu LY; Li YN; Feng YJ; Storr M
    Pancreas; 2013 Jan; 42(1):123-9. PubMed ID: 22850623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.
    Skaper SD; Facci L; Giusti P
    Mol Neurobiol; 2013 Oct; 48(2):340-52. PubMed ID: 23813098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease.
    Borrelli F; Fasolino I; Romano B; Capasso R; Maiello F; Coppola D; Orlando P; Battista G; Pagano E; Di Marzo V; Izzo AA
    Biochem Pharmacol; 2013 May; 85(9):1306-16. PubMed ID: 23415610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
    Romero TR; Resende LC; Guzzo LS; Duarte ID
    Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.